Targeting Cannabinoid CB(2) Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

Endocannabinoids activate two types of specific G-protein-coupled receptors (GPCRs), namely cannabinoid CB(1) and CB(2). Contrary to the psychotropic actions of agonists of CB(1) receptors, and serious side effects of the selective antagonists of this receptor, drugs acting on CB(2) receptors appear...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro, Gemma, Morales, Paula, Rodríguez-Cueto, Carmen, Fernández-Ruiz, Javier, Jagerovic, Nadine, Franco, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020102/
https://www.ncbi.nlm.nih.gov/pubmed/27679556
http://dx.doi.org/10.3389/fnins.2016.00406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020102/
https://www.ncbi.nlm.nih.gov/pubmed/27679556
http://dx.doi.org/10.3389/fnins.2016.00406

Ejemplares similares